Prenatal Diagnosis of a Giant Foetal Lymphangioma and Haemangiolymphoma in the Second Trimester Using 2D and 3D Ultrasound

Zusammenfassung

Lymphangiome sind gutartige Tumoren des lymphatischen Systems. Frühzeitige pränatale Diagnostik ist wichtig. Dies erlaubt eine Planung der Geburt, adäquate postpartale Versorgung des Kindes, Verbesserung der Prognose und einen frühzeitigen Schwangerschaftsabbruch im Falle einer ungünstigen Prognose. Wir berichten von 2 Fällen, einem Hämangiolymphangiom und einem Lymphangiom. Die 2D- und 3D-US-Charakteristiken werden präsentiert, die Differenzialdiagnosen, therapeutischen Optionen und die Prognose diskutiert.

Abstract.

Lymphangiomas are benign tumours of the lymphatic system. Early prenatal diagnosis is important to permit a planned delivery and provide adequate postnatal care. It thereby improves prognosis and allows the option of terminating the pregnancy if poor outcome is predicted. We report two cases, a giant haemangiolymphoma and a lymphangioma. 2D and 3D US findings are presented and differential diagnosis, therapeutic options and prognosis are discussed.

Schlüsselwörter

Hämangiolymphangiom - pränatale Diagnostik - Lymphangiom

Key words

Prenatal diagnosis - lymphangioma - Haemolymphangioma

References

• 1 Mittermayer C. Lymphangioma/Lymphohaemangioma at 2nd trimester. 4D examination online.  http://www.univie.ac.at/obgyn/prenatale_medizin/3d1.htm. 2002
• 2 Lee A, Deutinger J, Bernaschek G. Voluvision: Three-dimensional ultrasonography of foetal malformations.  Am J Obstet Gynecol. 1994;  170 1312-1314
• 3 Lee A, Deutinger J, Bernaschek G. Three dimensional ultrasound: abnormalities of the foetal face in surface and volume rendering mode.  Br J Obstet Gynecol. 1995;  102 302-306
• 4 Moore K L, Persaud T VN. The cardiovascular system. In: Moore KL, Persaud TVN, eds The Developing Human: Clinical Oriented Embryology.  Philadelphia: W.B: Saunders 1993: 349-351
• 5 Fonkalsrude E W. Congenital malformation of the lymphatic system.  Semin Pediatr Surg. 1994;  3 62-69
• 6 Allason J E. Lymphatic circulation. In: Stevenson RE, Hall JG, Goodman RS, eds Human Malformation and Related Anomalies.  New York: Oxford University Press 993: 293-304
• 7 Benacerraf B R. Syndrmes. In: Benacceraf BR, ed Ultrasound of Foetal Syndroms.  Philadelphia: Churchill Livingston 1998: 343-349
• 8 Shah K D, Chervenak F A, Marchevsky A M, Rosenberg J C, Berkovitz R L. Foetal giant haemangiolymphangioma: Report of a case.  Am J Perinatol. 1987;  4 212-214
• 9 Giacalone P L, Boulot P, Marty M, Deschmps F, Laffargue F, Viala J l. Foetal haemangiolymphoma: A case report.  Foetal Diagn Therapie. 1993;  8 338-340
• 10 Kaminopetros P, Jauniaux E, Weston M, Nicolaides K H, Campell D J. Prenatal diagnosis of an extensive foetal lymphangioma using ultrasonography, magnetic resonance imaging and cytology.  Br J Radiol.. 1997;  70 750-753
• 11 Romero R, Jeanty P, Ghidini A, Hobbins J. Prenatal Diagnosis of Congenital Anomalies.   Cystic Hygroma.  Norwalk, Connecticut: Appleton Lange 1988
• 12 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma.  J Pediatr Surg. 1994;  29 784-785
• 13 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy for lymphangiomas in children: why and how does it work?.  J Pediatr Sirg. 1996;  31 477-480
• 14 Schmidt B, Schimpl G, Hollwarth M E. OK-432 therapy of lymphangiomas in children.  Eu J Pediatr. 1996;  155 649-652
• 15 Ogita K, Suita S, Taguchi T, Yamanouchi T, Masumoto K, Tsukimori K, Nakano H. Outcome of foetal cystic hygroma and experience of intrauterine treatment.  Foetal Diagn Ther. 2001;  16(2) 105-110
• 16 Charabi B, Bretlau P, Bille M, Helmelund M. Cystic hygroma of the head and neck - a long-term follow-up of 44 cases.  Acta Otolaryngol Suppl. 2000;  543 248-250
• 17 Singh R K, Gutman M, Bucana C D, Sanchez R, Llansa R K, Fidler I J. Interferons α and β downregulate the expression of basic fibroblast growth factor in human carcinomas.  Proc Natl Acad Sci. 1995;  92 4562-4566
• 18 Klagsbrun M, D'Amore P A. Regulators of angiogenesis.  Ann Rev Physiol. 1991;  53 217-239
• 19 White C W, Sondheimer H M, Crouch E C, Wilson H, Fan L L. Treatment of pulmonary haemangiomatosis with recombinant interferon alpha-2a.  N Engl J Med. 1989;  320 1197-1200
• 20 Ezekowitz R AB, Mulliken J B, Folkman J. Interferon alpha-2a therapy for life-threatening hemangioma of infancy.  N Engl J Med. 1992;  326 1456-1463
• 21 Ricketts R R, Hatley R M, Corden B J, Sabio H, Howell C G. Interferon alpha-2a for the treatment of complex haemangiomas of infancy and childhood.  Ann Surg. 1994;  219 605-615
• 22 Hastings M M, Milot J, Barsoum-Homsy M, Hershon L, Dubois J, Leclerc J M. Recombinant interferon alpha-2a in the treatment of vision-threatening capillary hemangiomas in childhood.  JAAPOS. 1997;  1 226-230
• 23 Garmendia G, Miranda N, Borroso S, Longchong M, Martinez E, Ferrero J, Porrero P, Lopez-Saura P. Regression of infancy haemangiomas with recombinant IFN-α2b.  J Interferon Cytokine Res. 2001;  21 31-38
• 24 Merz E. DEGUM-Standards in Prenatal Level II Ultrasound Diagnosis (18 - 22 weeks of gestation).  Ultraschall in Med. 2001;  22(5) 199